In order to test the metabolic stability of 9-substituted cytokinins, 6-benzylamino-9-methyl purine has been synthesized and labeled with 14C in the 9-methyl carbon or doubly labeled with 14C in the 9-methyl carbon and 3H in the methylene moiety of the side chain. Although the 6-benzylamino-9-methylpurine is chemically stable, cytokinin-requiring tissues begin removing the 9-substituent in as little as 10 minutes. Among the various metabolic products is free benzylaminopurine. Thus, the biological activity of 9-substituted cytokinins could be accounted for by their conversion to the free base.
The widespread presence of cytokinins in the transfer RNA of animals, plants, and microorganisms is well established (see review by Key [14] ). Furthermore, in those cases where the primary structure is known, the cytokinin is found immediately adjacent to the presumed anticodon (1, 5, 17) . The continuing debate as to whether or not the physiological activity of exogenously supplied cytokinins is mediated by their presence in tRNA seems to have been recently resolved by the work of Chen and Hall (4) . Here it was shown that the potent cytokinin N6-(A2-isopentenyl) adenosine occurs in the tRNA of cultivated tobacco tissue even though the tissue requires an exogenous cytokinin in order to grow. The fact that the cytokinin supplied in the medium is not the metabolic precursor of the cytokinin in the tRNA argues that the role of the former is distinct in at least some important way from that of the latter.
This work, however, cannot be used as evidence against the notion that exogenous cytokinins act through their observed incorporation into polynucleotides (7, 9, 10) . One would need to demonstrate that cytokinins which are prevented from entering into nucleotide formation nevertheless retain all of their biological activity. It occurred to us that the use of blocking agents at the 9 position of the purine moiety would result in compounds which might yield information concerning the relation between nucleotide formation and biological activity of the I Supported by National Science Foundation Grants GB-6010 and GB-8319 and National Institutes of Health Grant GM-09902. 2 Part of this material is from a thesis presented by Chander Sood in partial fulfillment of the requirements for the Ph cytokinins. Accordingly, in July of 1967, we reported (11) the results of tests with the substance 6-benzylamino-9-(3-hydroxypropyl) purine. Although this material retains cytokinin activity, it is 10 to 100 times less effective than the corresponding free base; it is possible that the activity of the compound is due to its conversion to the free base in the plant tissue by removal of the substituent at the 9 position.
Earlier, Weaver et al. (22) reported that substituting benzyladenine at the 9 position with a tetrahydropyran ring yielded a compound with good biological activity, while Guern et al. (12) pointed out that several 9-substituted benzyladenines are active though seemingly not hydrolyzed in vivo. More recently Kende and Tavares (13) described studies with 6-benzylamino-9-methyl purine-benzyl-7-14C. Although radioactivity was incorporated into the RNA of soybean callus tissue when the free base was employed, methylation at the 9 position apparently prevented incorporation while in no way reducing biological activity of the cytokinin. Letham (16) and Young and Letham (23) reported that the 9-cyclohexyl analog of isopentenyladenine possesses considerable cytokinin activity; Letham considers that, "It is extremely unlikely that this compound with a group not subject to hydrolytic cleavage on the 9 position could be converted to a ribotide and incorporated into RNA as a nucleotide." (16) .
Likewise, Shaw et al. (21) reported that 9-methylzeatin gave biological activity of the same order as zeatin and concluded that, "The results imply that the mechanism of cytokinin activity in substituted adenines does not require prior formation of nucleotide derivatives."
Clearly, however, such conclusions are premature unless it is demonstrated directly that the substituent at the 9 position is not removed by the plant tissue and thus constitutes a truly effective block to ribonucleotide synthesis. In this paper the synthesis and biological activity of 9-methyl benzyladenine is described. In addition, evidence is presented which indicates that soybean and tobacco tissues remove substituents at the 9 position within a few minutes of incubation.
MATERIALS AND METHODS
Biological Tests. The origin of the soybean and tobacco tissues used here and their growth on various cytokinin and auxin levels have previously been described (8) . The basal medium and culture methods have been reported (6) . In some short term metabolic studies with labeled compounds, liquid media were used and the flasks were shaken. Compounds tested for cytokinin activity were sterilized at room temperature by filtration.
Synthesis and Characterization of 6-Benzylamino-9-methyl Purine. The 6-benzylaminopurine used in this and following synthetic procedures was prepared as previously described (9 (3) who report an increase in the selectivity of the alkylation which yields an increased ratio of the 9-to the 3-isomer as compared with earlier methods. In a typical synthesis 5.8 x 10-4 moles (130.2 mg) of BA were dissolved in 15 ml of anhydrous tetrahydrofuran to which were added 7.0 X 10-moles (27.3 mg) of metallic potassium. This mixture was stirred at room temperature under nitrogen for 12 hr after which 6.4 X 10-3 moles (912 mg) of methyl iodide was added, and the whole mixture was stirred for an additional 12 hr. The reaction flask was fitted to a condenser through which water at 0 C was circulated to prevent the escape of gaseous methyl iodide. The reaction mixture was then taken to dryness at 30 C under re-5 Abbreviations: BA: 6-benzylaminopurine; MBA: 6-benzylamino-9-methylpurine. duced pressure in a rotary evaporator. The dried material was dissolved in a small amount of ethyl acetate and streaked on 1-mm layers of aluminum oxide G (Merck) on glass plates activated at 60 C for 24 hr. The thin layer chromatogram was developed in a mixture of chloroform and benzene (9:1). In this system ultraviolet-absorbing material presumed to be 6-benzylamino-9-methyl purine migrated to an RF of 0.25 while the unreacted potassium salt of BA remained at the base line. In addition, at least two other ultraviolet-absorbing compounds could often be detected at RF 0.55 and at the solvent front; these were presumed to be other methylated derivatives although they were not further characterized. The ultraviolet quenching band at RF-0.25 was eluted from the alumina with ethanol and taken to dryness in vacuo. In the run described here 38 mg of product were recovered, which on the basis of the expected compound MBA, constitutes a 27% yield.
For further characterization and tests of biological activity, A mass spectrum of the compound (Fig. 1) shows a molecular ion at mle 239 which is consistent with a methyl-substituted benzyladenine. In addition, the fragmentation pattern of the compound is not unlike that of BA ( Fig. 2 ) with strong peaks in both at mle 91 and mle 106 identifiable respectively as the tropylium ion (C7H7+) and a species (C6H5CH2N+H) formed by the loss of the purine ring system (2) .
Paramagnetic resonance spectra (Table 1 , Fig. 3 ) indicate that the purine 2 and 8 positions are unsubstituted and support a 9-substituted structure assignment. That the substance is a 6-, 9-disubstituted adenine is likewise indicated by the ultraviolet absorption spectrum (Fig. 4) . Features of the spectrum which permit this conclusion are the shoulder on the high wavelength side of the maximum under alkaline conditions, and maxma in the region of 270 with little shift of variation in extinction coefficient with change in pH (15) .
Further evidence that the compound is substituted at the 9 position is provided by the infrared absorption spectrum ( 5). The infrared spectrum of BA exhibits typical weak absorption between 2800 to 2400 cm-l due to the acidic hydrogen on the 9 nitrogen (2) whereas the corresponding spectrum of the compound in question lacks this feature. Finally, the compound was not precipitated with AgNO3 under acidic conditions (0.05 N acetic acid) although BA precipitated immediately with this treatment.
MBA was also synthesized by a second method which provided still more evidence for its structure. In a typical experiment 81.5 mg of 6-chloro-9-methyl purine (Cyclo Chemical Co.) were refluxed in 20 ml of water with 0.1 ml of benzylamine for 6 hr. The reaction mixture was taken to dryness in a rotary evaporator and washed with a small amount of water at 0 C to remove residual benzylamine. The product was converted to the HCl salt and purified as described above. Crystalline material was recovered in a 68% yield and proved identical with the material synthesized by method 1. Synthesis of 6-Benzylamino-9-methyl Purine-methylJ4C. The preparation of the '4C-labeled compound was performed as in the first method described above except that the synthesis was carried out in a sealed reaction bomb. In this procedure 7.2 X 10-' moles of the potassium salt of BA were reacted with 0.5 mc of 14CH.I (Amersham Searle, batch 95) sp. act. 41.2 mc/ mmole, i.e., 12.1 ,umoles. After purification, 0.62 mg (2.6 X 10' moles) of the desired product were recovered. The specific radioactivity of the product as estimated with the aid of a Packard model 3375 liquid scintillation spectrometer was 43.0 mc/mM.
Synthesis of 6-Benzylamino-9-methyl Purine-methylJ4C-methy1ene-3H. The tritium, carbon 14 doubly labeled compound was synthesized by reducing N'-benzoylaminopurine (18) with lithium aluminum tritiide (New England Nuclear Corp., specific radioactivity 125 mc/mM). The reactants were refluxed in N-methyl morpholine overnight, taken to a small volume in vacuo, and subjected to chromatography on thin layers of silica gel in chloroform-methanol-i N NH40H (5:2:1), a procedure which conveniently separates benzyladenine from unreacted benzoyladenine. The tritiated BA then became the starting compound for methylation at the 9 position with 14CH3I as described above.
From this procedure 0.5 mg of doubly labeled MBA was recovered with specific radioactivities of ('4C) 10 mc/mM and (3H) 37 mc/mm. Fig. 6 ). This relative difference has been a consistent feature in repeated tests.
In addition, the activity of MBA has been contrasted with that of BA in the assay for cytokinins depending upon the initiation of deoxyisoflavone synthesis in soybean cultures described by Miller (19) . This test, which was performed by Carlos Miller in Bloomington, Indiana, indicated that the presence of a methyl group at the 9 position greatly interfered with the ability of BA to promote synthesis of deoxyisoflavones in soybean tissues incubated 45 hr in liquid medium (Fig. 7) . Some activity was noticed, however, at concentrations of MBA 10 to 100 times higher than the unsubstituted compound.
Metabolic Stability of the 9-Substituent. In order to test for metabolic cleavage of the 9-methyl moiety, soybean and tobacco tissues were incubated for varying periods on liquid or solid media containing MBA labeled with '4C in the 9-methyl carbon. The tissues employed in these studies were in the log phase of growth but starved for 72 hr prior to use on a basal medium, complete except for the cytokinin. At the end of the incubation period, the gases present in the flask were passed through a BA -LOG CONC. Influence of BA and MBA on the synthesis of deoxyisoflavones in soybean tissue; 0.6 g of finely chopped tissue was incubated for 45 hr at 26 C in 20 ml of medium and then extracted by the addition of 80 ml of 95% ethanol. The increase in absorbance at 260 nm of the extract is due largely to the synthesis of deoxyisoflavones stimulated by active cytokinins (19) . Each point is the average of three cultures. See Miller (19) for details of procedure. 1 See text for details of trapping and radioactivity estimation of released C02. 2 Experimental manipulations of the control flask were identical with the test flask except that the tissue was omitted. 3 Tissue (approximately 3 gm fresh weight/flask) was incubated with 10 ml of a standard culture medium containing 1 mg/I, i.e., 4.15 X l0-8 moles/10 ml, 6-benzylamino-9-methylpurine-methyl 14C sp. ac. 43 mc/mmole, i.e., 3.5 X 106 cpm/10 ml. Tissues were starved on a medium complete except for a cytokinin for 72 hr prior to use. column containing finely divided filter paper soaked in a concentrated solution of barium hydroxide in order to trap CO2. The filter paper was air-dried and suspended in a standard fluid for liquid scintillation spectrometry. In order to rule out the pos- sibility of microbial contamination during the manipulations required by the experiment, a control flask complete except for the tissue was subjected to the same operations for each experiment.
The results (Table III) A question crucial to this study is whether or not free BA appears during the metabolism of MBA. One ought to be able to detect this compound easily since it would be tritium labeled but devoid of "IC. However, Figure 8 shows that "4C is present in substantial amounts even at the RF of BA. Presumably, though, the 14C from the methyl group of MBA enters into the methyl pool and subsequently into a number of metabolites, some of which migrate into the same general area of the chromatogram as BA. In order to test for free BA, portions of the chromatogram having the proper RF were eluted in ethanol and the eluate cocrystallized with authentic, unlabeled BA from mixtures of ethanol and water. The product was sublimed and the resulting crystals were scraped from the walls of the sublimation tube directly into counting vials. Similar studies were performed on the incubation medium after tissue had been growing for either 6 hr or 4 days. In all cases the product was radioactive and contained largely tritium although a small amount of "4C was observed as well, probably due to a tenaciously bound contaminant. Thus, in one instance a sample which contained 3600 dpm tritium also registered 178 dpm of 14C. As much as 10% of the tritium counts in the liquid medium after 6 hours incubation with tobacco tissue was identified with BA.
The biological activity of MBA, which in our hands is at least 10 times less active than BA, is therefore probably best explained by its conversion in the tissue to the free base. The methyl group at the 9 position does not constitute an effective block as has been assumed by previous workers but is in fact rather readily metabolized by plant tissues. This finding makes suspect the presumed stability of other 9-substituted cytokinins. In the absence of information regarding their metabolic stability, one cannot, therefore, use the biological activity of 9-substituted cytokinins as evidence against the possibility that cytokinin activity depends upon nucleotide formation.
